Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

<p><strong>Introduction</strong></p> The inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac, Sinovac) has been widely used in a two-dose schedule. We assessed whether a third dose of the homologous or a different vaccine could boost immune responses. <p><strong...

Full description

Bibliographic Details
Main Authors: Costa Clemens, SA, Weckx, L, Clemens, R, Almeida Mendes, AV, Ramos Souza, A, Silveira, MBV, da Guarda, SNF, de Nobrega, MM, de Moraes Pinto, MI, Gonzalez, IGS, Salvador, N, Franco, MM, de Avila Mendonça, RN, Queiroz Oliveira, IS, de Freitas Souza, BS, Fraga, M, Aley, P, Bibi, S, Cantrell, L, Dejnirattisai, W, Liu, X, Mongkolsapaya, J, Supasa, P, Screaton, GR, Lambe, T, Voysey, M, Pollard, AJ
Other Authors: RHH-001 study team
Format: Journal article
Language:English
Published: Elsevier 2022

Similar Items